Flinn, S, Herbert, K, Graham, K, and Siegler, JC. Differential effect of metabolic alkalosis and hypoxia on high-intensity cycling performance. J Strength Cond Res 28(10): 2852-2858, 2014-The purpose of this study was to investigate the effects of sodium bicarbonate (NaHCO 3 ) ingestion and acute hypoxic exposure on repeated bouts of high-intensity cycling to task failure. Twelve subjects completed 4 separate intermittent cycling bouts cycling bouts to task failure (120% peak power output for 30-second interspersed with 30-second active recovery) under the following conditions: normoxia (F I O 2 % at 20.93%) alkalosis (NA), normoxia placebo (NP), hypoxia (F I O 2 % at 14.7%) alkalosis (HA), and hypoxia placebo (HP). For the NA and HA trials, the buffer solution (0.3 g$kg 21 of NaHCO 3 ) was dispensed into gelatin capsules and consumed over 90 minutes with 1 L of water. Whole-blood acidbase findings demonstrated metabolic alkalosis in both NA and HA before exercise (HCO 3 2 : 32.8 6 1.8 mmol$L 21 ). Time to task failure was significantly impaired in the hypoxic conditions (NA: 199.1 6 62.3 seconds, NP: 183.8 6 45.0 seconds, HA: 127.8 6 27.9 seconds, HP: 133.3 6 28.7 seconds; p , 0.001; h 2 = 0.7). There was no difference between the HA and HP conditions (p = 0.41); however the 2 normoxic conditions approached significance with the NA condition on average resulting in approximately 15-second improvement in time to task failure (p = 0.09). These findings suggest that an acute decline in F I O 2 % consistent with hypoxic exposure is more inhibiting than metabolic acidosis during intermittent highintensity cycling to task failure. In application, the use of hypoxia and NaHCO 3 concurrently to improve performance under these conditions does not seem warranted. Figure 2. Time to task failure (s) for the 4 trial conditions (NA, NP, HA, and HP). Data are presented as mean 6 SD. *Significantly different from hypoxic conditions (p , 0.001). NA = normoxia alkalosis; NP = normoxia placebo; HA = hypoxia alkalosis; HP = hypoxia placebo.Figure 3. Individual performance data represented as responders, nonresponders, and negative responders. Journal of Strength and Conditioning Research the TM | www.nsca.com